NCT00366600View on ClinicalTrials.gov

Study Evaluating HKI-272 Administered to Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

neratinib

HKI-272

Trial Locations (1)

98418

Northwest Kinetics, Tacoma

All Listed Sponsors
lead

Puma Biotechnology, Inc.

INDUSTRY

NCT00366600 - Study Evaluating HKI-272 Administered to Healthy Subjects | Biotech Hunter | Biotech Hunter